Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness

Clozapine‐induced gastroesophageal rumination in 22q11.2 Deletion Syndrome. A case report on gastroesophageal side effects management without renouncing clozapine's effectiveness

Abstract Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment‐resistant schizophrenia, even in 22qDS.

Bibliographic Details
Main Authors: Tommaso Accinni, Marianna Frascarelli, Francesco Ghezzi, Alessia Panzera, Antonino Buzzanca, Martina Fanella, Carlo Di Bonaventura, Luca Carlone, Nicoletta Girardi, Massimo Pasquini, Fabio Di Fabio
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Clinical Case Reports
Subjects:
genetics
pharmacology
psychiatry
Online Access:https://doi.org/10.1002/ccr3.4134

Internet

https://doi.org/10.1002/ccr3.4134

Similar Items